Synageva BioPharma Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 282

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 14

  • Investments
  • 1

Synageva BioPharma General Information

Description

Developer of medicines for rare diseases. The company's focus is on developing, delivering and commercializing products for rare diseases.

Contact Information

Formerly Known As
AviGenics, Avigenics Inc
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
Corporate Office
  • 33 Hayden Avenue
  • Lexington, MA 02421
  • United States
+1 (781) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synageva BioPharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Synageva BioPharma‘s full profile, request access.

Request a free trial

Synageva BioPharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medicines for rare diseases. The company's focus is on developing, delivering and commercializing products
Biotechnology
Lexington, MA
282 As of 2015
00000
00.00 0000-00-00
000000&0 00000

000000

t labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitat
0000 000000000
San Diego, CA
00 As of 0000
00000
000000000 00000

000000

agna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris
0000000000000
Pratteln, Switzerland
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Synageva BioPharma Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regulus Therapeutics Formerly VC-backed San Diego, CA 00 00000 000000000 00000
Santhera Pharmaceuticals Formerly VC-backed Pratteln, Switzerland 00 00000 000000000 00000
Exonate Venture Capital-Backed Cambridge, United Kingdom 00 00.000 00000000000 00.000
You’re viewing 3 of 3 competitors. Get the full list »

Synageva BioPharma Patents

Synageva BioPharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2820032-A1 Truncated lysosomal acid lipase Inactive 02-Mar-2012 0000000000
EP-2820032-A4 Truncated lysosomal acid lipase Inactive 02-Mar-2012 0000000000 0
US-20130330317-A1 Methods for treating lysosomal acid lipase deficiency Inactive 15-Feb-2012 0000000000
US-20140255383-A1 Recombinant human naglu protein and uses thereof Inactive 12-Oct-2011 000000000
CA-2852027-A1 Recombinant human naglu protein and uses thereof Inactive 12-Oct-2011 A61K38/47
To view Synageva BioPharma’s complete patent history, request access »

Synageva BioPharma Executive Team (15)

Name Title Board Seat Contact Info
Carsten Boess Chief Financial Officer & Senior Vice President
Thomas Tisch JD Director
Sanj Patel Founder, President, Director & Chief Executive Officer
Barry Quart Director
Peter Wirth JD Director
You’re viewing 5 of 15 executive team members. Get the full list »

Synageva BioPharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synageva BioPharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Synageva BioPharma‘s full profile, request access.

Request a free trial

Synageva BioPharma Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Trimeris 03-Nov-2011 0000000000 00000 Medical Supplies 0000 0000
To view Synageva BioPharma’s complete acquisitions history, request access »

Synageva BioPharma FAQs

  • When was Synageva BioPharma founded?

    Synageva BioPharma was founded in 1996.

  • Who is the founder of Synageva BioPharma?

    Sanj Patel and George Murphy are the founders of Synageva BioPharma.

  • Who is the CEO of Synageva BioPharma?

    Sanj Patel is the CEO of Synageva BioPharma.

  • Where is Synageva BioPharma headquartered?

    Synageva BioPharma is headquartered in Lexington, MA.

  • What is the size of Synageva BioPharma?

    Synageva BioPharma has 282 total employees.

  • What industry is Synageva BioPharma in?

    Synageva BioPharma’s primary industry is Biotechnology.

  • Is Synageva BioPharma a private or public company?

    Synageva BioPharma is a Private company.

  • What is the current valuation of Synageva BioPharma?

    The current valuation of Synageva BioPharma is 00.00.

  • What is Synageva BioPharma’s current revenue?

    The current revenue for Synageva BioPharma is 000000.

  • How much funding has Synageva BioPharma raised over time?

    Synageva BioPharma has raised $429M.

  • Who are Synageva BioPharma’s investors?

    BB Biotech, Baker Brothers Investments, Baker-Tisch Investment Partners, Clinola Partners, and Cordova Ventures are 5 of 17 investors who have invested in Synageva BioPharma.

  • Who are Synageva BioPharma’s competitors?

    Regulus Therapeutics, Santhera Pharmaceuticals, and Exonate are competitors of Synageva BioPharma.

  • When was Synageva BioPharma acquired?

    Synageva BioPharma was acquired on 22-Jun-2015.

  • Who acquired Synageva BioPharma?

    Synageva BioPharma was acquired by Alexion.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »